["Immune type" haemolysis in course of L. dopa-benserazide therapeutic (author's transl)].
D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced*; D001545:Benserazide / Q000009:adverse effects* / Q000627:therapeutic use; D003298:Coombs Test; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000009:adverse effects*; D007980:Levodopa / Q000009:adverse effects* / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy
D006834:Hydrazines; D007980:Levodopa; D001545:Benserazide
Hémolyse de type "immun" au cours d'un traitement par L. dopa-bensérazide.